- Home
- HOTH vs GELS Comparison
HOTH vs GELS Comparison
Compare HOTH & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- GELS
- Stock Information
- Founded
- HOTH 2017
- GELS 2018
- Country
- HOTH United States
- GELS Australia
- Employees
- HOTH N/A
- GELS N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- HOTH Health Care
- GELS
- Exchange
- HOTH Nasdaq
- GELS NYSE
- Market Cap
- HOTH 15.6M
- GELS 15.9M
- IPO Year
- HOTH 2019
- GELS 2024
- Fundamental
- Price
- HOTH $1.31
- GELS $1.62
- Analyst Decision
- HOTH Strong Buy
- GELS
- Analyst Count
- HOTH 3
- GELS 0
- Target Price
- HOTH $4.00
- GELS N/A
- AVG Volume (30 Days)
- HOTH 426.2K
- GELS 192.7K
- Earning Date
- HOTH 05-12-2025
- GELS 02-15-2025
- Dividend Yield
- HOTH N/A
- GELS N/A
- EPS Growth
- HOTH N/A
- GELS N/A
- EPS
- HOTH N/A
- GELS N/A
- Revenue
- HOTH N/A
- GELS $233,830.00
- Revenue This Year
- HOTH N/A
- GELS N/A
- Revenue Next Year
- HOTH N/A
- GELS N/A
- P/E Ratio
- HOTH N/A
- GELS N/A
- Revenue Growth
- HOTH N/A
- GELS 10.19
- 52 Week Low
- HOTH $0.58
- GELS $0.77
- 52 Week High
- HOTH $3.80
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- HOTH 51.27
- GELS N/A
- Support Level
- HOTH $1.21
- GELS N/A
- Resistance Level
- HOTH $1.41
- GELS N/A
- Average True Range (ATR)
- HOTH 0.10
- GELS 0.00
- MACD
- HOTH -0.01
- GELS 0.00
- Stochastic Oscillator
- HOTH 41.30
- GELS 0.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.